F-group (family)
7515.1.1.6 Phosphodiest
Ligands and drugs
589
Member domains
340
with ligand contacts (≤ 4 Å)
57.7% of members
136
with DrugDomain annotations
23.1% of members
108
with a DrugBank compound
18.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7515.1.1.6 belongs to X-group 7515 Alkaline phosphatase-like, which binds 9.5 ligand superclasses per 20 proteins, broader than 88% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 72 |
| DB00131 | AMP | Adenosine phosphate | 11 |
| DB00529 | PPF | Foscarnet | 4 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 3 |
| DB08834 | 5D5 | Tauroursodeoxycholic acid | 3 |
| DB01643 | TMP | Thymidine monophosphate | 2 |
| DB02596 | APC | alpha,beta-Methyleneadenosine 5'-triphosphate | 2 |
| DB03397 | UD1 | Uridine-Diphosphate-N-Acetylglucosamine | 2 |
| DB03403 | C5P | Cytidine-5'-Monophosphate | 2 |
| DB03945 | PC | N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium | 2 |
| DB15403 | 7NB | Ziritaxestat | 2 |
| DB16767 | IRH | Isorhamnetin | 2 |
| DB00470 | TCI | Dronabinol | 1 |
| DB02823 | PAE | Phosphonoacetic Acid | 1 |
| DB04557 | ACD | Arachidonic Acid | 1 |
| DB06408 | — | Taribavirin | 1 |
| DB09459 | TLA | L-tartaric acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 331 |
| CL | CHLORIDE ION | 142 |
| CAmetal | CALCIUM ION | 114 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 55 |
| SCN | THIOCYANATE ION | 32 |
| IOD | IODIDE ION | 31 |
| 5JK | 7alpha-hydroxycholesterol | 15 |
| AMP | ADENOSINE MONOPHOSPHATE | 11 |
| NKP | (2R)-2-hydroxy-3-(phosphonooxy)propyl (9E)-octadec-9-enoate | 6 |
| NAmetal | SODIUM ION | 5 |
| 6ZO | (3,5-dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate | 4 |
| PPF | PHOSPHONOFORMIC ACID | 4 |
| 5D5 | 2-{[(3alpha,5beta,7alpha,8alpha,14beta,17alpha)-3,7-dihydroxy-24-oxocholan-24-yl]amino}ethanesulfonic acid | 3 |
| BR | BROMIDE ION | 3 |
| T8R | 5,7-bis(oxidanyl)-2-(1-pentylindol-3-yl)chromen-4-one | 3 |
| 4NY | 4-{(Z)-2-[6-chloro-1-(4-fluorobenzyl)-1H-indol-3-yl]-1-cyanoethenyl}benzoic acid | 2 |
| 4O2 | 3-[(11aS)-6-(4-fluorobenzyl)-1,3-dioxo-5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indol-2(3H)-yl]propanoic acid | 2 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 2 |
| 6ZM | 1-{2-[(2,3-dihydro-1H-inden-2-yl)amino]-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl}ethan-1-one | 2 |
| 6ZN | 6-(3-{2-[(2,3-dihydro-1H-inden-2-yl)amino]-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl}propanoyl)-1,3-benzoxazol-2(3H)-one | 2 |